Mizuho initiated coverage on Hutchison China MediTech
$HCM
Biotechnology: Pharmaceutical Preparations
Health Care
Mizuho initiated coverage of Hutchison China MediTech with a rating of Buy
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/13/2025 | Buy → Hold | HSBC Securities | |
| 11/24/2023 | Hold → Buy | Deutsche Bank | |
| 5/4/2022 | Buy → Hold | Deutsche Bank | |
| 9/22/2021 | $46.00 | Buy → Neutral | Goldman |
| 8/3/2021 | $52.00 | Buy | Jefferies |
6-K - HUTCHMED (China) Ltd (0001648257) (Filer)
6-K - HUTCHMED (China) Ltd (0001648257) (Filer)
6-K - HUTCHMED (China) Ltd (0001648257) (Filer)
HSBC Securities downgraded HUTCHMED from Buy to Hold
Deutsche Bank upgraded HUTCHMED from Hold to Buy
Deutsche Bank downgraded HUTCHMED from Buy to Hold